This evidence-based guide explains what the c
Patience during the first month is essential, as the initiation phase is about tolerance building, not weight loss
It also calls for regular monitoring of liver enzymes, weight, appetite tolerance, and blood glucose once treatment is underway
Gastrointestinal side effects such as nausea and vomiting, common during treatment initiation, may further compromise nutritional status
Researchers with metabolic syndrome, elevated liver enzymes, or suspected NAFLD have a metabolic profile that aligns well with the dual benefits of tirzepatide (glycemic control, appetite reduction) and levocarnitine (enhanced hepatic fat oxidation, improved insulin sensitivity at the cellular level)